Connecting the Dots From Patients to Researchers with Jason Colquitt – CEO of Across Healthcare
Jason Colquitt is the CEO of Across Healthcare and he has 20 years experience in the healthcare technology field where his work has caused a positive disruption within the healthcare industry. He was diagnosed with carnitine palmitoyltransferase type II deficiency (CPT-II), a rare mitochondrial disease. He believes he’s been called to use his journey and technical background to help the rare disease community.
Can you share your background and a bot about what you do?
There’s a Walt Whitman quote that talks about a journey and how you never understand that journey until looking backwards and that’s what I do a lot– look back and see how all the paths crossed, what I’ve been blessed to be able to do and how I can bless others. I’ve been in healthcare technology for 22 years and have done and seen a lot. Personally, about 18 years ago I realized something wasn’t right after several hospitalizations. I had a great primary physician and my diagnostic journey was quick. I was sent to the University of Alabama at Birmingham which has an amazing rare disease group. They did a muscle biopsy and quickly determined that I had a rare mitochondrial disease called CPT-II. This part of my journey gives me the passion for what I do today.
What did you feel seeing another patient with your disease on Diagnosis?
I have gone through her same pains, though she had it more severe than I do. Going on a walk and locking up, being crippled and subsequently hospitalized, I could relate on a lot of levels. I had never seen anyone with my disease, so it was interesting and a chance to digest that I do have a rare disease and others do too.
What is Across Healthcare?
How does someone sign up for the Matrix?
What advancements have you seen in medical technology, data and what can be gathered from digitizing and organizing?
What is the cost for a rare disease group to join the platform?
Who are your rare disease heroes?
LINKS AND RESOURCES MENTIONED
TUNE INTO THE ONCE UPON A GENE PODCAST
CONNECT WITH EFFIE PARKS